231 related articles for article (PubMed ID: 10562307)
1. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4.
Peakman M; Stevens EJ; Lohmann T; Narendran P; Dromey J; Alexander A; Tomlinson AJ; Trucco M; Gorga JC; Chicz RM
J Clin Invest; 1999 Nov; 104(10):1449-57. PubMed ID: 10562307
[TBL] [Abstract][Full Text] [Related]
2. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR4-associated T and B cell responses to specific determinants on the IA-2 autoantigen in type 1 diabetes.
McLaughlin KA; Gulati K; Richardson CC; Morgan D; Bodansky HJ; Feltbower RG; Christie MR
J Immunol; 2014 Nov; 193(9):4448-56. PubMed ID: 25225671
[TBL] [Abstract][Full Text] [Related]
4. Two distinctly HLA-associated contiguous linear epitopes uniquely expressed within the islet antigen 2 molecule are major autoantibody epitopes of the diabetes-specific tyrosine phosphatase-like protein autoantigens.
Bearzatto M; Naserke H; Piquer S; Koczwara K; Lampasona V; Williams A; Christie MR; Bingley PJ; Ziegler AG; Bonifacio E
J Immunol; 2002 Apr; 168(8):4202-8. PubMed ID: 11937581
[TBL] [Abstract][Full Text] [Related]
5. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
6. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
7. Proliferative responses to selected peptides of IA-2 in identical twins discordant for Type 1 diabetes.
Schulz RM; Hawa M; Leslie RD; Sinigaglia F; Passini N; Rogge L; Picard JK; Londei M
Diabetes Metab Res Rev; 2000; 16(3):150-6. PubMed ID: 10867713
[TBL] [Abstract][Full Text] [Related]
8. T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes.
Hawkes CJ; Schloot NC; Marks J; Willemen SJ; Drijfhout JW; Mayer EK; Christie MR; Roep BO
Diabetes; 2000 Mar; 49(3):356-66. PubMed ID: 10868956
[TBL] [Abstract][Full Text] [Related]
9. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents.
Honeyman MC; Stone NL; Harrison LC
Mol Med; 1998 Apr; 4(4):231-9. PubMed ID: 9606176
[TBL] [Abstract][Full Text] [Related]
10. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
[TBL] [Abstract][Full Text] [Related]
11. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.
Kelemen K; Gottlieb PA; Putnam AL; Davidson HW; Wegmann DR; Hutton JC
J Immunol; 2004 Mar; 172(6):3955-62. PubMed ID: 15004204
[TBL] [Abstract][Full Text] [Related]
12. Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.
Harfouch-Hammoud E; Walk T; Otto H; Jung G; Bach JF; van Endert PM; Caillat-Zucman S
Diabetes; 1999 Oct; 48(10):1937-47. PubMed ID: 10512357
[TBL] [Abstract][Full Text] [Related]
13. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).
Payton MA; Hawkes CJ; Christie MR
J Clin Invest; 1995 Sep; 96(3):1506-11. PubMed ID: 7657822
[TBL] [Abstract][Full Text] [Related]
14. T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus.
Dotta F; Dionisi S; Viglietta V; Tiberti C; Matteoli MC; Cervoni M; Bizzarri C; Marietti G; Testi M; Multari G; Lucentini L; Di Mario U
Eur J Endocrinol; 1999 Sep; 141(3):272-8. PubMed ID: 10474125
[TBL] [Abstract][Full Text] [Related]
15. HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition.
Amria S; Hajiaghamohseni LM; Harbeson C; Zhao D; Goldstein O; Blum JS; Haque A
Eur J Immunol; 2008 Jul; 38(7):1961-70. PubMed ID: 18506881
[TBL] [Abstract][Full Text] [Related]
16. Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM.
Genovese S; Bonfanti R; Bazzigaluppi E; Lampasona V; Benazzi E; Bosi E; Chiumello G; Bonifacio E
Diabetologia; 1996 Oct; 39(10):1223-6. PubMed ID: 8897011
[TBL] [Abstract][Full Text] [Related]
17. Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2.
Seissler J; Schott M; Morgenthaler NG; Scherbaum WA
Clin Exp Immunol; 2000 Nov; 122(2):157-63. PubMed ID: 11091269
[TBL] [Abstract][Full Text] [Related]
18. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.
Hawa M; Rowe R; Lan MS; Notkins AL; Pozzilli P; Christie MR; Leslie RD
Diabetes; 1997 Aug; 46(8):1270-5. PubMed ID: 9231650
[TBL] [Abstract][Full Text] [Related]
19. GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9.
Itoh A; Shimada A; Kodama K; Morimoto J; Suzuki R; Oikawa Y; Irie J; Nakagawa Y; Shigihara T; Kanazawa Y; Okubo Y; Motohashi Y; Maruyama T; Saruta T
Ann N Y Acad Sci; 2004 Dec; 1037():33-40. PubMed ID: 15699491
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule.
van Lummel M; van Veelen PA; de Ru AH; Pool J; Nikolic T; Laban S; Joosten A; Drijfhout JW; Gómez-Touriño I; Arif S; Aanstoot HJ; Peakman M; Roep BO
Diabetes; 2016 Mar; 65(3):732-41. PubMed ID: 26718497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]